A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic
Authors
Keywords
-
Journal
Orphanet Journal of Rare Diseases
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-02
DOI
10.1186/s13023-021-01757-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psychological morbidity among children with transfusion dependent β-thalassaemia and their parents in Sri Lanka
- (2020) Sachith Mettananda et al. PLoS One
- The Essential Role of Patient Blood Management in a Pandemic
- (2020) Aryeh Shander et al. ANESTHESIA AND ANALGESIA
- Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic
- (2020) Michael R. DeBaun BLOOD
- A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
- (2020) M. Domenica Cappellini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic
- (2020) Robert Sheppard Nickel et al. BLOOD
- COVID‐19 and thalassaemia: A position statement of the Thalassaemia International Federation
- (2020) Dimitrios Farmakis et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials
- (2020) Muhammad Ashar Ali et al. EXPERIMENTAL HEMATOLOGY
- Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements
- (2020) Syed A K Shifat Ahmed et al. BMJ Global Health
- Blood transfusion therapy for β‐thalassemia major and hemoglobin E β‐thalassemia: Adequacy, trends, and determinants in Sri Lanka
- (2019) Sachith Mettananda et al. PEDIATRIC BLOOD & CANCER
- Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia
- (2019) Shuqian Xu et al. BLOOD
- Hydroxyurea-Induced miRNA Expression in Sickle Cell Disease Patients in Africa
- (2019) Khuthala Mnika et al. Frontiers in Genetics
- Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia
- (2019) Sachith Mettananda et al. Scientific Reports
- Blood Rheology: Key Parameters, Impact on Blood Flow, Role in Sickle Cell Disease and Effects of Exercise
- (2019) Elie Nader et al. Frontiers in Physiology
- Molecular Basis and Genetic Modifiers of Thalassemia
- (2018) Sachith Mettananda et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia
- (2018) Rosario Di Maggio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
- (2018) Joseph Sleiman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sickle cell disease
- (2018) Gregory J. Kato et al. Nature Reviews Disease Primers
- Pharmacoproteomics Profiling of Plasma From β-Thalassemia Patients in Response to Hydroxyurea Treatment
- (2018) Muhammad Zohaib et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa
- (2018) Léon Tshilolo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: Impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway
- (2018) Elie Nader et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Comparison of MicroRNAs Mediated in Reactivation of the γ-Globin in β-Thalassemia Patients, Responders and Non-Responders to Hydroxyurea
- (2017) Mohammad T. Hojjati et al. HEMOGLOBIN
- Sickle Cell Disease
- (2017) Frédéric B. Piel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxyurea for lifelong transfusion-dependent β-thalassemia: A meta-analysis
- (2017) Ali H. Algiraigri et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
- (2017) Sachith Mettananda et al. Nature Communications
- Effects of hydroxyurea treatment for patients with hemoglobin SC disease
- (2016) Lori Luchtman-Jones et al. AMERICAN JOURNAL OF HEMATOLOGY
- Pathophysiology and treatment of pulmonary hypertension in sickle cell disease
- (2016) V. R. Gordeuk et al. BLOOD
- Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia
- (2016) Sachith Mettananda et al. HAEMATOLOGICA
- A ribonucleotide reductase inhibitor with deoxyribonucleoside-reversible cytotoxicity
- (2016) Mikael Crona et al. Molecular Oncology
- Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia
- (2016) Sachith Mettananda et al. HAEMATOLOGICA
- Understanding α-globin gene regulation and implications for the treatment of β-thalassemia
- (2015) Sachith Mettananda et al. Annals of the New York Academy of Sciences
- Beyond soluble transferrin receptor: Old challenges and new horizons
- (2015) Kristian Harms et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- -Globin as a molecular target in the treatment of -thalassemia
- (2015) S. Mettananda et al. BLOOD
- Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia
- (2015) N. Lemonne et al. HAEMATOLOGICA
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease
- (2015) Gift D Pule et al. Expert Review of Hematology
- Patient-specific blood rheology in sickle-cell anaemia
- (2015) Xuejin Li et al. Interface Focus
- Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia
- (2015) N. Lemonne et al. HAEMATOLOGICA
- Optimizing hydroxyurea therapy for sickle cell anemia
- (2015) R. E. Ware Hematology-American Society of Hematology Education Program
- STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
- (2015) Seham Ragab Mediterranean Journal of Hematology and Infectious Diseases
- Haptoglobin testing in hemolysis: Measurement and interpretation
- (2014) Andrew W.Y. Shih et al. AMERICAN JOURNAL OF HEMATOLOGY
- Hydroxyurea-inducible SAR1 gene acts through the Gi /JNK/Jun pathway to regulate -globin expression
- (2014) J. Zhu et al. BLOOD
- Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports
- (2014) Mehran Karimi et al. Hematology
- Report on Patients with Non Transfusion-Dependent β-Thalassemia Major Being Treated with Hydroxyurea Attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013
- (2014) Mehrnoush Kosaryan et al. HEMOGLOBIN
- Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review
- (2014) Michael R DeBaun Expert Review of Hematology
- Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
- (2014) Mohammad Reza Bordbar et al. Iranian Red Crescent Medical Journal
- Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?
- (2013) Mehdi Banan ANNALS OF HEMATOLOGY
- Cistanche deserticola decoction alleviates the testicular toxicity induced by hydroxyurea in male mice
- (2013) Li Gu et al. ASIAN JOURNAL OF ANDROLOGY
- Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity
- (2013) S. C. Rogers et al. BLOOD
- Clinical experience with fetal hemoglobin induction therapy in patients with -thalassemia
- (2013) K. M. Musallam et al. BLOOD
- Hydroxyurea in Sickle Cell Disease: Drug Review
- (2013) Rohit Kumar Agrawal et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Reawakening fetal hemoglobin: prospects for new therapies for the -globin disorders
- (2012) D. E. Bauer et al. BLOOD
- Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia
- (2012) Jonathan M. Flanagan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hydroxyurea responsiveness in -thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity
- (2012) F. Pourfarzad et al. HAEMATOLOGICA
- A Biophysical Indicator of Vaso-occlusive Risk in Sickle Cell Disease
- (2012) D. K. Wood et al. Science Translational Medicine
- Fetal hemoglobin in sickle cell anemia
- (2011) I. Akinsheye et al. BLOOD
- Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia
- (2011) A. L. Walker et al. BLOOD
- Pulmonary hypertension and NO in sickle cell
- (2010) M. T. Gladwin et al. BLOOD
- Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia
- (2010) Rachid Haidar et al. EUROPEAN SPINE JOURNAL
- The proteome of sickle cell disease: insights from exploratory proteomic profiling
- (2010) Susan Yuditskaya et al. Expert Review of Proteomics
- Hydroxyurea for Children with Sickle Cell Disease
- (2010) Matthew M. Heeney et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Early Detection of Response to Hydroxyurea Therapy in Patients with Sickle Cell Anemia
- (2010) Samir K. Ballas et al. HEMOGLOBIN
- Hydroxyurea and Acute Painful Crises in Sickle Cell Anemia: Effects on Hospital Length of Stay and Opioid Utilization During Hospitalization, Outpatient Acute Care Contacts, and at Home
- (2010) Samir K. Ballas et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
- (2009) E. Voskaridou et al. BLOOD
- Response to hydroxyurea in β thalassemia major and intermedia: Experience in western India
- (2009) Khushnooma Y. Italia et al. CLINICA CHIMICA ACTA
- In vivo pharmaco-proteomic analysis of hydroxyurea induced changes in the sickle red blood cell membrane proteome
- (2009) Swati S. Ghatpande et al. Journal of Proteomics
- IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES INDUCED BY HYDROXYUREA IN RETICULOCYTES FROM SICKLE CELL ANAEMIA PATIENTS
- (2008) LS Moreira et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Monocyte Protein Signatures of Disease Severity in Sickle Cell Anemia
- (2008) Anita Hryniewicz-Jankowska et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- The Genomic Analysis of Erythrocyte microRNA Expression in Sickle Cell Diseases
- (2008) Shao-Yin Chen et al. PLoS One
- Erythroid adhesion molecules in sickle cell disease: Effect of hydroxyurea
- (2008) J.-P. Cartron et al. TRANSFUSION CLINIQUE ET BIOLOGIQUE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now